Jame Abraham

Summary

Affiliation: West Virginia University
Country: USA

Publications

  1. doi request reprint Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging
    Jame Abraham
    Department of Medicine, Section of Hematology and Oncology, Johns Hopkins University, Baltimore, MD, USA
    Clin Breast Cancer 8:88-91. 2008
  2. pmc Initial clinical test of a breast-PET scanner
    Raymond R Raylman
    Department of Radiology Hematology Oncology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV, USA
    J Med Imaging Radiat Oncol 55:58-64. 2011
  3. ncbi request reprint Increased risk of brain metastases in patients with HER-2/neu-positive breast carcinoma
    Ramin Altaha
    Section of Hematology Oncology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia, USA
    Cancer 103:442-3. 2005
  4. ncbi request reprint Actinic keratosis and capecitabine therapy
    Gerald M Higa
    Department of Medicine, Section of Hematology Oncology, West Virginia University, Morgantown, USA
    J Oncol Pharm Pract 11:151-3. 2005
  5. doi request reprint Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats
    Gregory W Konat
    Department of Neurobiology and Anatomy, West Virginia University School of Medicine, 4052 HSCN, P O Box 9128, Morgantown, WV 26506 9128, USA
    Metab Brain Dis 23:325-33. 2008
  6. ncbi request reprint Thymic hyperplasia after adjuvant chemotherapy in breast cancer
    Aasim S Sehbai
    Section of Hematology Oncology, West Virginia University, Morgantown, WV 26506 9162, USA
    J Thorac Imaging 21:43-6. 2006
  7. ncbi request reprint Paraneoplastic neurologic syndrome associated with occult breast cancer: a case report and review of literature
    Ramin Altaha
    West Virginia University Hospital, Section of Hematology Oncology, Mary Babb Randolph Cancer Center, Morgantown, West Virginia 26506 9162, USA
    Breast J 9:417-9. 2003
  8. ncbi request reprint Lapatinib in the treatment of breast cancer
    Gerald M Higa
    Mary Babb Randolph Cancer Center, School of Pharmacy, West Virginia University, Morgantown, WV 26506, USA
    Expert Rev Anticancer Ther 7:1183-92. 2007
  9. ncbi request reprint CNS metastasis in primary breast cancer
    Manish Sharma
    Mary Babb Randolph Cancer Center Clinic, West Virginia University, PO Box 9162, Morgantown, WV 26506 9162, USA
    Expert Rev Anticancer Ther 7:1561-6. 2007
  10. ncbi request reprint Anemia and neutropenia associated with copper deficiency of unclear etiology
    William Harless
    Division of Hematology and Oncology, West Virginia University, Morgantown, 26506, USA
    Am J Hematol 81:546-9. 2006

Collaborators

Detail Information

Publications27

  1. doi request reprint Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging
    Jame Abraham
    Department of Medicine, Section of Hematology and Oncology, Johns Hopkins University, Baltimore, MD, USA
    Clin Breast Cancer 8:88-91. 2008
    ..The purpose of this study was to examine the effect of adjuvant chemotherapy on normal-appearing white matter in women with breast cancer...
  2. pmc Initial clinical test of a breast-PET scanner
    Raymond R Raylman
    Department of Radiology Hematology Oncology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV, USA
    J Med Imaging Radiat Oncol 55:58-64. 2011
    ..Specifically, the main task of this study is to determine whether the new system can successfully be used to produce images of known breast cancer and compare them to those acquired by standard techniques...
  3. ncbi request reprint Increased risk of brain metastases in patients with HER-2/neu-positive breast carcinoma
    Ramin Altaha
    Section of Hematology Oncology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia, USA
    Cancer 103:442-3. 2005
  4. ncbi request reprint Actinic keratosis and capecitabine therapy
    Gerald M Higa
    Department of Medicine, Section of Hematology Oncology, West Virginia University, Morgantown, USA
    J Oncol Pharm Pract 11:151-3. 2005
    ..During treatment, an apparent toxic skin reaction occurs before dermal quiescence ensues. We report a case of a typical flare of AK in a woman treated with capecitabine for advanced breast cancer...
  5. doi request reprint Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats
    Gregory W Konat
    Department of Neurobiology and Anatomy, West Virginia University School of Medicine, 4052 HSCN, P O Box 9128, Morgantown, WV 26506 9128, USA
    Metab Brain Dis 23:325-33. 2008
    ..Moreover, the results strongly indicate that the damaging effect is mediated by oxidative stress, as memory dysfunction is preventable by the co-administration of NAC...
  6. ncbi request reprint Thymic hyperplasia after adjuvant chemotherapy in breast cancer
    Aasim S Sehbai
    Section of Hematology Oncology, West Virginia University, Morgantown, WV 26506 9162, USA
    J Thorac Imaging 21:43-6. 2006
    ..Awareness of this unusual side effect in patients treated with chemotherapy may prevent unnecessary investigation and surgical intervention...
  7. ncbi request reprint Paraneoplastic neurologic syndrome associated with occult breast cancer: a case report and review of literature
    Ramin Altaha
    West Virginia University Hospital, Section of Hematology Oncology, Mary Babb Randolph Cancer Center, Morgantown, West Virginia 26506 9162, USA
    Breast J 9:417-9. 2003
    ..Only 29% of patients responded to chemotherapy with improvement in neurologic deficits. The role of systemic treatment in the progression of neurologic impairment is unclear...
  8. ncbi request reprint Lapatinib in the treatment of breast cancer
    Gerald M Higa
    Mary Babb Randolph Cancer Center, School of Pharmacy, West Virginia University, Morgantown, WV 26506, USA
    Expert Rev Anticancer Ther 7:1183-92. 2007
    ..Recently, lapatinib, a small molecule dual inhibitor of both HER2 and EGF receptors, has been developed to expand the options for treating HER-positive breast cancer...
  9. ncbi request reprint CNS metastasis in primary breast cancer
    Manish Sharma
    Mary Babb Randolph Cancer Center Clinic, West Virginia University, PO Box 9162, Morgantown, WV 26506 9162, USA
    Expert Rev Anticancer Ther 7:1561-6. 2007
    ..This review focuses on the treatment options available for both brain and leptomeningeal metastasis from breast cancer, including some investigational therapies that may be of importance in patient management in the near future...
  10. ncbi request reprint Anemia and neutropenia associated with copper deficiency of unclear etiology
    William Harless
    Division of Hematology and Oncology, West Virginia University, Morgantown, 26506, USA
    Am J Hematol 81:546-9. 2006
    ....
  11. ncbi request reprint Perioperative management of a patient with May-Hegglin anomaly requiring craniotomy
    Aasim S Sehbai
    Section of Hematology Oncology, West Virginia University School of Medicine, Morgantown, West Virginia 26505, USA
    Am J Hematol 79:303-8. 2005
    ..With this approach, the use of platelet concentrates could be avoided. We discuss the role of DDAVP in MHA and related platelet disorders and review the current literature...
  12. doi request reprint Prognostic significance of the "surprise" question in cancer patients
    Alvin H Moss
    West Virginia University, Morgantown, West Virginia 26506, USA
    J Palliat Med 13:837-40. 2010
    ..It has not been previously studied in patients with cancer...
  13. doi request reprint Role of MRI in screening, diagnosis and management of breast cancer
    Anil Kumar Swayampakula
    Department of Community Medicine, School of Medicine, West Virginia University, Morgantown, WV 26506, USA
    Expert Rev Anticancer Ther 8:811-7. 2008
    ..This article focuses on the role of MRI in diagnosis, screening and management of breast cancer, and reviews the current indications for breast MRI...
  14. ncbi request reprint Managing early breast cancer: prognostic features guide choice of therapy
    Hamid R Mirshahidi
    Mary Babb Randolph Cancer Center, West Virginia University, Morgantown 26505, USA
    Postgrad Med 116:23-6, 32-4. 2004
    ..Here, the authors present the current considerations and treatment guidelines for early-stage breast cancer...
  15. ncbi request reprint High-dose therapy and autologous stem cell transplantation in relapsed and refractory Hodgkin's disease: outcome based on a prognostic model
    Muzaffar H Qazilbash
    Blood and Marrow Transplantation Program, West Virginia University, Morgantown, W VA, USA
    Acta Haematol 110:173-8. 2003
    ..The use of a prognostic model appears useful for predicting the outcome of HDT and ASCT for HD patients, and may play an important role in choosing the appropriate therapy for these patients...
  16. ncbi request reprint Role of tumor markers and circulating tumors cells in the management of breast cancer
    Ayman Saad
    Department of Internal Medicine School of Medicine West Virginia University, WV 26506 9162, USA
    Oncology (Williston Park) 22:726-31; discussion 734, 739, 743-4. 2008
    ..This article will discuss the current data on these markers, with special emphasis on the CTC test. The potential clinical utility of these markers will also be discussed...
  17. doi request reprint Correlation among [18F]fluorodeoxyglucose positron emission tomography/computed tomography, cancer antigen 27.29, and circulating tumor cell testing in metastatic breast cancer
    Ayman Saad
    Neoplastic Diseases and Related Disorders, Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
    Clin Breast Cancer 8:357-61. 2008
    ..Recently, circulating tumor cell testing (CTC) has been used in this context. It is not known if 1 of the 3 tests can be a surrogate for another...
  18. ncbi request reprint Cognitive impairment with significant brain parenchymal volume loss following standard adjuvant chemotherapy in a patient with breast cancer
    Anil Kumar Swayampakula
    Department of Community Medicine, Mary Babb Randolph Cancer Center, West Virginia University School of Medicine, Morgantown, WV 26506, USA
    Clin Adv Hematol Oncol 5:985-7; discussion 987-8. 2007
  19. doi request reprint Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients
    Hui Huang
    Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Cancer 113:2020-8. 2008
    ..A long-term follow-up was conducted of 18 patients with a diagnosis of pheochromocytoma/paraganglioma treated with a combination of cyclophosphamide, vincristine, and dacarbazine (CVD)...
  20. doi request reprint Ixabepilone: a new microtubule-targeting agent for breast cancer
    Gerald M Higa
    Mary Babb Randolph Cancer Center, School of Pharmacy, West Virginia University, Morgantown, WV 26506, USA
    Expert Rev Anticancer Ther 8:671-81. 2008
    ....
  21. ncbi request reprint Population-based molecular prognosis of breast cancer by transcriptional profiling
    Yan Ma
    Mary Babb Randolph Cancer Center, Department of Statistics, Division of Hematology, West Virginia University, Morgantown, WV 26506 9300, USA
    Clin Cancer Res 13:2014-22. 2007
    ..The purpose of this study is to predict breast cancer recurrence and metastases and to identify gene signatures indicative of clinicopathologic characteristics using gene expression patterns derived from cDNA microarray...
  22. ncbi request reprint Epidermal growth factor receptor as a target for cancer therapy
    Ramin Altaha
    Expert Rev Anticancer Ther 7:1-3. 2007
  23. ncbi request reprint Breast and ovarian cancer genetics and prevention
    Ramin Altaha
    Section of Hematology Oncology, Mary Babb Randolph Cancer Center, West Virginia University Hospitals, Morgantown, USA
    W V Med J 99:187-91. 2003
    ..Likewise, genetic counseling prior to testing is important, considering the major impact of the test results on an individual's life...
  24. ncbi request reprint Phase I trial and pharmacokinetic study of BMS-247550, an epothilone B analog, administered intravenously on a daily schedule for five days
    Jame Abraham
    Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, USA
    J Clin Oncol 21:1866-73. 2003
    ..BMS-247550 is a semisynthetic analog of the natural product epothilone B. We conducted a phase I study administering BMS-247550 as a 1-hour intravenous infusion daily for 5 consecutive days every 21 days...
  25. pmc Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases
    Bradford J Wood
    Special Procedures, Department of Diagnostic Radiology, Clinical Center, National Institutes of Health Clinical Center, Bethesda, Maryland, USA
    Cancer 97:554-60. 2003
    ....
  26. ncbi request reprint Epothilones: a novel class of non-taxane microtubule-stabilizing agents
    Ramin Altaha
    West Virginia University, Mary Babb Randolph Cancer Center, Robert C Byrd Health Sciences Center, Morgantown, West Virginia, 26506, USA
    Curr Pharm Des 8:1707-12. 2002
    ..This article will review some basic aspects of epothilone chemistry and biology, and pre-clinical and preliminary clinical experience with epothilone B and its analog, BMS 247550...
  27. ncbi request reprint A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist
    Jame Abraham
    Medicine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Cancer 94:2333-43. 2002
    ....